BIOCHEM INTERNATIONAL INC
15-12G, 1999-02-03
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Previous: TRUST FOR UNITED STATES TREASURY OBLIGATIONS, DEF 14A, 1999-02-03
Next: FLEETWOOD ENTERPRISES INC/DE/, 8-K, 1999-02-03



<PAGE>   1

                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D.C.  20549

                                    FORM 15

  CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g)
      OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE
  REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

                        Commission File Number: 0-10005

                           Biochem International Inc.
- -------------------------------------------------------------------------------
             (Exact Name of registrant as specified in its charter)

           N7 W22025 Johnson Road, Waukesha, WI  53186 (414) 542-3100
 -----------------------------------------------------------------------------
         (Address, including zip code, and telephone number, including
            area code, of registrant's principal executive offices)

                          Common Stock, $.02 par value
- -------------------------------------------------------------------------------
            (Title of each class of securities covered by this Form)

                                      None
- -------------------------------------------------------------------------------
           (Title of all other classes of securities for which a duty
             to file reports under Section 13(a) or 15(d) remains)

         Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file reports:


Rule 12g-4(a)(1)(i)           X            Rule 12h-3(b)(1)(i)           X
                          --------                                   --------
Rule 12g-4(a)(1)(ii)                       Rule 12h-3(b)(1)(ii)
                          ----------                                 ----------
Rule 12g-4(a)(2)(i)                        Rule 12h-3(b)(2)(i)
                          ----------                                 ----------
Rule 12g-4(a)(2)(ii)                       Rule 12h-3(b)(2)(ii)
                          ----------                                 ----------
                                           Rule 15d-6
                                                                     ----------

         Approximate number of holders of record as of the certification or
notice date:    1
              -----

         Pursuant to the requirements of the Securities Exchange Act of 1934,
Biochem International Inc. has caused this certification/notice to be signed on
its behalf by the undersigned duly authorized person.


Date: January 11, 1999                     By:         /s/ Frank Katarow
                                                   ----------------------------
                                                   Frank Katarow
                                                   President




Instruction:  This form is required by Rule 12g-4, 12h-3 and 15d-6 of the
General Rules and Regulations under the Securities Exchange Act of 1934. The
registrant shall file with the Commission three copies of Form 15, one of which
shall be manually signed.  It may be signed by an officer of the registrant, by
counsel or by any other duly authorized person.  The name and title of the
person signing the form shall be typed or printed under the signature.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission